We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

90 hedge funds and large institutions have $156M invested in BioSpecifics Technologies Corp. in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 48 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 16

17% more capital invested

Capital invested by funds: $134M → $156M (+$22.6M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

1% less funds holding

Funds holding: 91 → 90 (-1)

Holders
90
Holders Change
-1
Holders Change %
-1.1%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
48
Reduced
16
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$4.35M
2
NI
Numeric Investors
Massachusetts
+$2.14M
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$1.55M
4
Prudential Financial
Prudential Financial
New Jersey
+$972K
5
Renaissance Technologies
Renaissance Technologies
New York
+$813K

Top Sellers

Rank Fund Capital Flow
1
ACA
Abdiel Capital Advisors
New York
-$11.8M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.84M
3
GCP
GSA Capital Partners
United Kingdom
-$1.69M
4
Millennium Management
Millennium Management
New York
-$683K
5
OAM
Oxford Asset Management
United Kingdom
-$441K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
26
Putnam Investments
Massachusetts
$2.17M +$686K +18,730 +52%
TC
27
TFS Capital
Pennsylvania
$2.09M -$77.5K -2,116 -4%
Invesco
28
Invesco
Georgia
$2.05M +$264K +7,205 +16%
TCIM
29
TIAA CREF Investment Management
New York
$1.79M +$211K +5,772 +15%
Charles Schwab
30
Charles Schwab
California
$1.79M – – –
GCP
31
GSA Capital Partners
United Kingdom
$1.74M -$1.69M -46,200 -51%
First Manhattan
32
First Manhattan
New York
$1.73M – – –
Geode Capital Management
33
Geode Capital Management
Massachusetts
$1.66M +$16.8K +459 +1%
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.59M +$101K +2,771 +7%
Two Sigma Investments
35
Two Sigma Investments
New York
$1.59M -$203K -5,541 -12%
DCM
36
DAFNA Capital Management
California
$1.59M – – –
Goldman Sachs
37
Goldman Sachs
New York
$1.46M +$93.2K +2,544 +7%
BIM
38
Bogle Investment Management
Massachusetts
$1.38M +$513K +14,013 +68%
SCM
39
Stonepine Capital Management
Oregon
$1.2M +$160K +4,363 +17%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$1.05M -$125K -3,400 -11%
BA
41
BlackRock Advisors
Delaware
$1.03M +$10.5K +287 +1%
BCM
42
Bridgeway Capital Management
Texas
$995K – – –
MCM
43
Matarin Capital Management
New York
$940K -$25.3K -692 -3%
CCM
44
Cadence Capital Management
Massachusetts
$855K +$784K +21,398 New
BIM
45
BlackRock Investment Management
Delaware
$854K +$137K +3,738 +21%
TAM
46
Tocqueville Asset Management
New York
$799K – – –
HIP
47
Hatteras Investment Partners
North Carolina
$787K -$89.9K -2,455 -11%
ACM
48
Ativo Capital Management
Illinois
$782K +$300K +8,200 +72%
IP
49
Isthmus Partners
Wisconsin
$695K +$637K +17,395 New
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$670K – – –
1
2
3 4

BSTC Hedge Fund Activity: Q2 2016 in Review

90 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2016, worth a combined $156M — up 17% from $134M a quarter earlier.

Fund positioning in BSTC was balanced in Q2 2016: 9 funds opened new positions, 9 closed out, 48 added to existing stakes and 16 trimmed.

The largest buyer was Eagle Asset Management, opening a new position worth an estimated $4.35M. The largest seller was Abdiel Capital Advisors, exiting entirely with an estimated $11.8M sold.

  • 90 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2016, down from 91 in Q1 2016.
  • Funds reported $156M of BioSpecifics Technologies Corp. stock for Q2 2016, up 17% quarter-over-quarter.
  • 9 funds opened new BioSpecifics Technologies Corp. positions in Q2 2016 and 9 closed out, a net change of 0 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2016 was Eagle Asset Management, an estimated $4.35M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2016 was Abdiel Capital Advisors, an estimated $11.8M sold.

Based on aggregated 13F filings for Q2 2016.